Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.61 USD | +2.35% | +6.53% | +53.53% |
04-23 | Capital One Starts Heron Therapeutics With Overweight Rating, $6 Price Target | MT |
03-21 | Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024 | CI |
Business Summary
Number of employees: 126
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutic Innovations
100.0
%
| 108 | 100.0 % | 127 | 100.0 % | +17.99% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 108 | 100.0 % | 127 | 100.0 % | +17.99% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 20/02/23 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 15/06/23 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 31/10/18 |
Chief Tech/Sci/R&D Officer | 65 | 29/03/12 | |
John C. Arthur
PRN | Corporate Officer/Principal | 58 | 31/12/16 |
Sean T. Ristine
HRO | Human Resources Officer | 54 | 31/07/14 |
William Forbes
PRN | Corporate Officer/Principal | 62 | 05/06/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 20/02/23 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 19/09/21 |
Craig Johnson
BRD | Director/Board Member | 62 | 12/01/14 |
Christian Waage
BRD | Director/Board Member | 57 | 21/06/16 |
Adam Morgan
CHM | Chairman | 45 | 20/02/23 |
Director/Board Member | 49 | 19/09/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 150,636,976 | 149,593,378 ( 99.31 %) | 0 | 99.31 % |
Company contact information
Heron Therapeutics, Inc.
4242 Campus Point Court Suite 200
92121, San Diego
+858 251 4400
http://www.herontx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.53% | 393M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- HRTX Stock
- Company Heron Therapeutics, Inc.